Annual Total Long Term Liabilities
$677.02 M
+$630.04 M+1341.06%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual total long term liabilities is $677.02 million, with the most recent change of +$630.04 million (+1341.06%) on December 31, 2023.
- During the last 3 years, RNAC annual total long term liabilities has risen by +$575.13 million (+564.44%).
- RNAC annual total long term liabilities is now at all-time high.
Performance
RNAC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$433.16 M
+$10.08 M+2.38%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly total long term liabilities is $433.16 million, with the most recent change of +$10.08 million (+2.38%) on September 1, 2024.
- Over the past year, RNAC quarterly long term liabilities has increased by +$27.81 million (+6.86%).
- RNAC quarterly long term liabilities is now -36.02% below its all-time high of $677.02 million, reached on December 31, 2023.
Performance
RNAC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RNAC Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1341.1% | +6.9% |
| 3 y3 years | +564.4% | +822.0% |
| 5 y5 years | +4488.1% | +822.0% |
RNAC Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1341.1% | -36.0% | +1581.1% |
| 5 y | 5-year | at high | +1341.1% | -36.0% | +1581.1% |
| alltime | all time | at high | +4488.1% | -36.0% | +3325.3% |
Cartesian Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $433.16 M(+2.4%) |
| Jun 2024 | - | $423.08 M(+4.4%) |
| Mar 2024 | - | $405.35 M(-40.1%) |
| Dec 2023 | $677.02 M(+1341.1%) | $677.02 M(+2527.6%) |
| Sep 2023 | - | $25.77 M(-42.3%) |
| Jun 2023 | - | $44.69 M(-18.1%) |
| Mar 2023 | - | $54.58 M(+16.2%) |
| Dec 2022 | $46.98 M(-27.8%) | - |
| Dec 2022 | - | $46.98 M(-32.5%) |
| Sep 2022 | - | $69.63 M(+7.6%) |
| Jun 2022 | - | $64.70 M(+27.6%) |
| Mar 2022 | - | $50.69 M(-22.2%) |
| Dec 2021 | $65.11 M(-36.1%) | $65.11 M(-27.9%) |
| Sep 2021 | - | $90.28 M(-7.4%) |
| Jun 2021 | - | $97.45 M(-12.8%) |
| Mar 2021 | - | $111.71 M(+9.6%) |
| Dec 2020 | $101.89 M | $101.89 M(-8.5%) |
| Sep 2020 | - | $111.37 M(+69.4%) |
| Jun 2020 | - | $65.75 M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $67.49 M(+20.0%) |
| Dec 2019 | $56.23 M(+281.1%) | $56.23 M(+275.3%) |
| Sep 2019 | - | $14.98 M(-0.0%) |
| Jun 2019 | - | $14.98 M(+2.5%) |
| Mar 2019 | - | $14.62 M(-0.9%) |
| Dec 2018 | $14.76 M(-61.5%) | $14.76 M(-6.0%) |
| Sep 2018 | - | $15.69 M(-55.5%) |
| Jun 2018 | - | $35.28 M(-3.5%) |
| Mar 2018 | - | $36.55 M(-4.6%) |
| Dec 2017 | $38.31 M(+85.6%) | $38.31 M(+15.0%) |
| Sep 2017 | - | $33.33 M(+77.4%) |
| Jun 2017 | - | $18.79 M(-3.5%) |
| Mar 2017 | - | $19.46 M(-5.7%) |
| Dec 2016 | $20.64 M(-86.4%) | $20.64 M(+63.2%) |
| Sep 2016 | - | $12.65 M(-7.0%) |
| Jun 2016 | - | $13.60 M(-3.3%) |
| Mar 2016 | - | $14.06 M(-90.7%) |
| Dec 2015 | $152.03 M(+50.9%) | $152.03 M |
| Dec 2014 | $100.75 M | - |
FAQ
- What is Cartesian Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual total long term liabilities year-on-year change?
- What is Cartesian Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly long term liabilities year-on-year change?
What is Cartesian Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RNAC is $677.02 M
What is the all time high annual total long term liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual total long term liabilities is $677.02 M
What is Cartesian Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RNAC annual total long term liabilities has changed by +$630.04 M (+1341.06%)
What is Cartesian Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RNAC is $433.16 M
What is the all time high quarterly long term liabilities for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly total long term liabilities is $677.02 M
What is Cartesian Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RNAC quarterly total long term liabilities has changed by +$27.81 M (+6.86%)